On April 13, 2018, a putative class of employees filed a motion asking the Honorable Dale A. Drozd, of the U.S. District Court for the Eastern District of California, for preliminary approval of a proposed deal under which Roadrunner Intermodal Services LLC, Central Cal Transportation LLC, and Morgan Southern Inc. (collectively, "Defendants") will pay $9.2 million to settle claims against them alleging that they misclassified employees as independent contractors.
On April 19, 2018, California resident Kevin Branca ("Plaintiff"), on behalf of himself and all others similarly situated, filed a putative class action against drink maker, Bai Brands LLC ("Defendant"), accusing the company of using misleading packaging that suggests its products are made with "all-natural" ingredients even though they are artificially flavored.
On April 16, 2018, the Honorable James Donato, of the U.S. District Court for the Northern District of California, granted class certification to a group of Illinois Facebook users ("Plaintiffs") who claim that the social media company, Facebook, Inc. ("Facebook" or "Defendant"), scanned images of their faces as part of its "Tag Suggestions" feature without first obtaining their consent, in violation of Illinois' Biometric Information Privacy Act ("BIPA").
On April 11, 2018, a putative class of employees led by Jacquette Smith (collectively, "Plaintiffs") filed a lawsuit in Illinois state court alleging their employer, Andy Frain Services Inc. ("Defendant"), was collecting and storing their personal information through a finger-scan timekeeping device, in violation of the Illinois Biometric Information Privacy Act ("BIPA").
On February 16, 2018, Allergan Inc. ("Allergan"), Senju Pharmaceutical Co. Ltd., and Kyorin Pharmaceutical Co. Ltd. (collectively, "Defendants") announced a proposed settlement in which they will pay Hartig Drug Co. Inc. ("Plaintiff") $9 million to end a class action over alleged "product hopping" related to eye care products, Zymar and Zymaxid. Product hopping is a term used to describe the practice of pharmaceutical companies making modest drug reformulations that offer little or no therapeutic advantages in an effort to obstruct generic competitors and preserve monopoly profits on a patented drug. In 2012, the Federal Trade Commission filed an amicus brief stating that product hopping undermines state and federal laws that encourage generic competition and explained that the conduct can be the basis for an antitrust lawsuit.
On February 16, 2018, U.S. District Judge Beth Bloom, of the U.S. District Court for the Southern District of Florida, dismissed a proposed class action against Uber Technologies Inc. ("Uber"), the suit alleged Uber's rule prohibiting drivers from carrying a gun violates their constitutional rights. Judge Bloom found that Jose Mejia ("Plaintiff"), an Uber driver proposing to lead a class of all persons similarly situated, failed to plead an injury in fact, and, therefore, lacked standing to sue.
On January 16, 2018, Judge Ronald B. Leighton, of the United States District Court for the Western District of Washington, ruled that Ford Motor Company ("Ford") must face some of the claims in a proposed class action over allegedly defective sunroofs that can spontaneously shatter.
On January 10, 2018, supply chain company, Geodis LLC ("Geodis"), announced a proposed deal in which it will pay approximately $2.9 million to settle employment claims brought against Ozburn-Hessey Logistics LLC ("Ozburn-Hessey") ("Defendant"), which was acquired by Geodis in 2015.
On Tuesday, November 7, 2017, a class of employees led by former United baggage handler, David Johnson (collectively, the "Plaintiffs"), sued United Airlines Inc. ("United" or "Defendant") under the Illinois Biometric Information Privacy Act ("BIPA"). The suit claims United's timekeeping system, which requires employees to clock-in and clock-out using their fingerprints, does not comply with BIPA regulations.